S‐1 vs 5‐FU‐containing regimens
Progression‐free survival · people with advanced gastric cancer
S‐1 showed no clear difference in progression‐free survival compared with 5‐FU‐containing regimens (low certainty).
1 finding from 1 review
- HR 0.85 [0.7, 1.04]4 studies · 1942 participantsLow